KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vertex Pharmaceuticals (VRTX) Minority Interest (2016 - 2018)

Vertex Pharmaceuticals has reported Minority Interest over the past 8 years, most recently at $28.4 million for Q3 2018.

  • Quarterly results put Minority Interest at $28.4 million for Q3 2018, up 133.13% from a year ago — trailing twelve months through Sep 2018 was $28.4 million (up 133.13% YoY), and the annual figure for FY2017 was $13.7 million, down 92.44%.
  • Minority Interest for Q3 2018 was $28.4 million at Vertex Pharmaceuticals, down from $28.7 million in the prior quarter.
  • Over the last five years, Minority Interest for VRTX hit a ceiling of $196.0 million in Q2 2017 and a floor of $12.2 million in Q3 2017.
  • Median Minority Interest over the past 5 years was $153.5 million (2015), compared with a mean of $106.9 million.
  • Biggest five-year swings in Minority Interest: surged 654.87% in 2016 and later plummeted 93.49% in 2017.
  • Vertex Pharmaceuticals' Minority Interest stood at $21.2 million in 2014, then skyrocketed by 625.6% to $153.7 million in 2015, then rose by 18.19% to $181.6 million in 2016, then tumbled by 92.44% to $13.7 million in 2017, then skyrocketed by 106.64% to $28.4 million in 2018.
  • The last three reported values for Minority Interest were $28.4 million (Q3 2018), $28.7 million (Q2 2018), and $29.8 million (Q1 2018) per Business Quant data.